Matthew Rauen, M.D.
Dr. Matt Rauen graduated from Loras College with a B.S. in Biology Research and received his medical degree from The University of Iowa Carver College of Medicine. He completed his Ophthalmology Residency in 2009 at the University of Iowa Department of Ophthalmology & Visual Sciences when he began a fellowship in Cornea, External Disease, and Refractive Surgery in the same department.
Dr. Rauen was a Doris Duke Clinical Research Fellow at The University of Iowa and worked on projects regarding identification of mutations in human eye diseases. His work identified a mutation in the gene GCAP1 in a family with cone-rod dystrophy.
Dr. Rauen finished his Cornea Fellowship in June 2010 and is now in private practice at the Wolfe Eye Clinic, West DesMoines, Iowa.
Burtelow MA, Roos-Mattjus PM, Rauen M, Babendure JR, Karnitz LM. Reconstitution and molecular analysis of the hRad9-hHus1-hRad1 (9-1-1) DNA damage responsive checkpoint complex. J Biol Chem. 2001 Jul 13;276(28):25903-9.
Rauen M, Burtelow MA, Dufault VM, Karnitz LM. The human checkpoint protein hRad17 interacts with the PCNA-like proteins hRad1, hHus1, and hRad9. J Biol Chem. 2000 Sep 22;275(38):29767-71.
Roos-Mattjus P, Vroman BT, Burtelow MA, Rauen M, Eapen AK, Karnitz LM. Genotoxin-induced Rad9-Hus1-Rad1 (9-1-1) chromatin association is an early checkpoint signaling event. J Biol Chem. 2002 Nov 15;277(46):43809-12.
Rauen M, Oetting TA, Weingeist TA. Valsalva Retinopathy: Vision loss after asthma attack. EyeRounds.org. Posted July 10, 2007; Available from: http://EyeRounds.org/cases/67-Valsalva-Retinopathy-Vision-Loss-Asthma.htm